Effect of administration of interferon alfa 2-b in treatment of pterygium

Phase 3

• Conditions: Pterygium of eye; pterygium of eye.; H11.0

• Registration Number: IRCT20120817010617N5
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients with pure Pterygium that involve at least 1mm cornea based on clinical diagnosis

Exclusion Criteria

Any eye pathology other than pterygium

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pterygium size. Timepoint: Patients will be examined after 48 hours, one week, and then monthly for 6 months after injection. Method of measurement: Based on slit lamp examination.;Photophobia. Timepoint: Patients will be examined after 48 hours, one week, and then monthly for 6 months after injection. Method of measurement: Based on slit lamp examination.;Pterygium Hyperemia. Timepoint: Patients will be examined after 48 hours, one week, and then monthly for 6 months after injection. Method of measurement: slit lamp examination.